West Gastroenterology Medical Group
Industry / private company
Location:
Diverse,
United States (USA) (US)
ISNI: -
Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis (2020)
Danese S, Neurath M, Kopoń A, Zakko SF, Simmons TC, Fogel R, Siegel CA, et al.
Journal article
Apremilast for active ulcerative colitis: a phase 2, randomised, double-blind, placebo-controlled induction study (2018)
Danese S, Neurath M, Kopon A, Zakko S, Simmons T, Fogel R, Maccarone J, et al.
Conference contribution